Drug company Sanofi is recalling all epinephrine auto-injectors in North America. The devices are used to treat severe allergic and anaphylactic reactions. The devices are being recalled because they may not dispense the correct dose of the life-saving drug. All of its epinephrine injectors the company has sold in Canada under the brand name Allerject.FNHA clients using Allerject epinephrine auto-injectors should contact their pharmacists. Their Allerject device will be replaced with an Epipen auto-injector.Please note: In the event a life-threatening allergic reaction (anaphylaxis) occurs before you can obtain a replacement auto injector, use your Allerject device as directed by your healthcare provider, then call 911 and seek emergency medical attention.For more information, visit http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2015/55620a-eng.php